Many experts and drug industry leaders consider Brazil to be the largest drug market in the world. Not only does Brazil have a large population with more than 200 million people, but the drug consumption rates in this country are quite high. As a result, many drug and pharmaceutical companies have been vying to get approved for the import of their products into Brazil.
Recently, the government of Brazil approved the import of Real Scientific Hemp Oil™ as a medication for chronic pain. RSHO™ is a cannabidiol (CBD) hemp oil product produced by Medical Marijuana, Inc. While chronic pain was the third indication for the import of RSHO™, the first two indications were Parkinson’s disease and epilepsy. Shareholders of Medical Marijuana, Inc. (OTC: MJNA) will be happy to know that many experts report that there is much to look forward to in terms of the market and opportunity for RSHO™ and other CBD hemp oil products in Brazil.
Drug Laws in Brazil
While marijuana for recreational use is still considered illegal in Brazil, many believe that the recreational use of marijuana is on the brink of being decriminalized. In Brazil, there have been many movements pushing for the decriminalization of the use of marijuana. In fact, due to these movements, the Brazilian Supreme Court has considered legalizing marijuana for recreational use on more than one occasion.